Skip to Main Content

Paper Details

Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review.
Ann Clin Transl Neurol
6
2023
multiple sclerosis, ocrelizumab, patient, patients, people, primary progressive multiple sclerosis, relapsing remitting multiple sclerosis
Author NameAffiliation
Xavier Montalban
Paul M MatthewsUK Dementia Research Institute Centre at Imperial College London
  • 1 - 2

Datasets

Release 1.2